[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100594613":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":33,"centralContacts":38,"locations":46,"responsibleParty":48,"collaborators":46,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":46,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":46,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":74,"whyStopped":46,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":46},{"fullName":5,"class":6},"Rehman Medical Institute - RMI","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Regime 1","ACTIVE_COMPARATOR","This arm will receive clarithromycin based regimen for eradication of H pylori infection (as per approved guidelines)",[13],"Drug: Clarithromycin",{"label":15,"type":10,"description":16,"interventionNames":17},"Regime 2","This arm will receive levofloxacin based regimen for eradication of H pylori infection (as per approved guidelines)",[18],"Drug: Levofloxacin",[20,28],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Clarithromycin","Drug regimens will be given for 14 days, and omeprazole for 6weeks",[9],[26,27],"Metronidazole","omeprazole",{"type":21,"name":29,"description":23,"armGroupLabels":30,"otherNames":31},"Levofloxacin",[15],[32,27],"amoxicillin",[34],{"name":35,"affiliation":36,"role":37},"Wajeeha Qayyum, FCPS","Rehman Medical Institute","PRINCIPAL_INVESTIGATOR",[39,44],{"name":35,"role":40,"phone":41,"phoneExt":42,"email":43},"CONTACT","092915838000","3638","wajeeha.qayyum@rmi.edu.pk",{"name":45,"role":40,"phone":41,"phoneExt":46,"email":47},"Taimur Khan, FCPS",null,"taimur.khan@rmi.edu.pk",{"type":37,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":46,"oldOrganization":46},"Wajeeha Qayyum","Consultant\u002FAssistant Professor Medicine","100594613","phase-4-comparison-of-two-treatment-regimens-of-helicobacter-pylori-infection-100594613",false,"NCT07021729","Comparison of Two Treatment Regimens of Helicobacter Pylori Infection","Comparison of Conventional Clarithromycin Vs Alternative Levofloxacin Based Regimen in Treatment of Helicobacter Pylori Infection","Inclusion Criteria:\n\n* All patients who tested positive on stool antigen will be included.\n\nExclusion Criteria:\n\n* patients under 12 years old. Patients who have penicillin allergy.\n* Patients who have underlying dysrhythmia forbidding the use of macrolide.\n* Patient who have hypersensitivity to any of these antibiotics.","ALL","12 Years","90 Years",{"count":62,"type":63},156,"ESTIMATED","INTERVENTIONAL",[66],"PHASE4","The goal of this interventional study is to compare the efficacy of clarithromycin Vs levofloxacin based regimen in treatment of Helicobacter pylori infection in patients presenting to medical OPD who are tested positive for H pylori infection.. The main question\\[s\\] it aims to answer are:\n\n• Which regimen is superior in terms of efficacy Participants will be treated for H pylori Infection in with two different regimen If there is a comparison group: Researchers will compare two groups Group 1 will receive clarithromycin based regimen group 2 will receive levofloxacin based regimen to see the treatment response.",[69],"Helicobacter Pylori Infection",[71,72,73],"clarithromycin","levofloxacin","helicobacter pylori","NOT_YET_RECRUITING","2025-06-11",{"date":77,"type":78},"2025-06-15","ACTUAL",{"date":80,"type":63},"2025-12",{"date":82,"type":63},"2026-06",{"name":5,"class":6}]